PlainBillCongress, translated.Legislation. Context. Public interest.

HOPE Act

Referred to the House Committee on Energy and Commerce.

Official summary

Version 82 · Passed Senate without amendment · Apr 11, 2007

(This measure has not been amended since it was introduced. The summary has been expanded because action occurred on the measure.)

Hope Offered through Principled and Ethical Stem Cell Research Act or the HOPE Act - (Sec. 3) Amends the Public Health Service Act to require the Secretary of Health and Human Services to develop techniques for the isolation, derivation, production, or testing of stem cells, including pluripotent stem cells that have the flexibility of embryonic stem cells (whether or not they have an embryonic source), that may result in improved understanding of or treatments for diseases and other adverse health conditions, provided that such techniques do not involve: (1) the creation of a human embryo or embryos for research purposes; or (2) the destruction or discarding of, or risk of injury to, a human embryo of embryos other than those that are naturally dead.

Requires the Secretary to: (1) provide guidance concerning the next steps required for additional research; (2) prioritize research with the greatest potential for near-term clinical benefits; (3) take into account techniques outlined by the President's Council on Bioethics and any other appropriate techniques and research; and (4) require assurances from grant applicants, in the case of research involving stem cells from a naturally dead embryo, that no alteration of the timing, methods, or procedures used to create, maintain, or intervene in the development of a human embryo was made solely for the purpose of deriving the stem cells.

Showing the opening paragraphs of the official summary.

Read full official summaryShow less

Sets forth reporting requirements.

Authorizes appropriations.

(Sec. 4) Directs the Secretary to enter into a contract with the Institute of Medicine to conduct a study to: (1) recommend an optimal structure for an amniotic and placental stem cell bank program; and (2) address pertinent issues to maximize the potential of such technology.

Read the summary on Congress.gov
PlainBill analysis is coming later. This page presents official source data. We have not yet published a PlainBill explanation for this bill.

Who introduced it

Sen. Coleman, Norm [R-MN] · R–MN

Committees

  • Energy and Commerce Committee
6 cosponsorship records, including any withdrawals

Actions

A procedural vote is different from passage. Passage in one chamber does not establish enactment. Explore the glossary.

  1. Referred to the House Committee on Energy and Commerce.

  2. Received in the House.

  3. Message on Senate action sent to the House.

  4. Passed Senate, having acquired the 60 votes required under unanimous consent, without amendment by Yea-Nay Vote. 70 - 28. Record Vote Number: 128. (text as passed Senate: CR S4390-4391)

    Senate roll call 128 · Individual votes
  5. Passed/agreed to in Senate: Passed Senate, having acquired the 60 votes required under unanimous consent, without amendment by Yea-Nay Vote. 70 - 28. Record Vote Number: 128.(text as passed Senate: CR S4390-4391)

    Senate roll call 128 · Individual votes
  6. Considered by Senate. (consideration: CR S4319-4371, S4386-4391)

  7. Measure laid before Senate by unanimous consent. (consideration: CR S4237-4294)

  8. Introduced in the Senate and read twice and ordered held at desk.

  9. Introduced in Senate

Bill text & related measures

Text links open the official source. We currently store references to these documents.

Related bills identified by Congress.gov

No related bills are listed in this snapshot. This does not establish whether the proposal has appeared in earlier Congresses.

Source last updated: Jan 2, 2025. Consult Congress.gov for the current record.

Explore the bill from different angles

Choose a perspective, copy a prompt, and paste it into your preferred AI. Each prompt includes the bill version and available official source links, and asks for counterarguments as well as supporting evidence.

Neutral evidence review

Objective

Analyze S.30 as objectively as possible. Explain its main provisions, who would be affected, possible benefits and harms, implementation, exceptions, and uncertainties. Present the strongest arguments for and against it, and identify evidence needed to assess its public impact.

View full prompt & sources
Fairness and public impact

Progressive lens

Examine S.30 through a progressive lens, focusing on fairness, access, economic inequality, and effects on vulnerable communities. Explain potential benefits, costs, and unintended consequences. Consider the strongest counterarguments and distinguish stated goals from demonstrated outcomes.

View full prompt & sources
Institutions and government scope

Conservative lens

Examine S.30 through a conservative lens, focusing on fiscal responsibility, institutional stability, federalism, and the scope of government. Explain potential benefits, costs, and unintended consequences. Consider the strongest counterarguments and any provisions that challenge this perspective.

View full prompt & sources
Individual rights and government power

Liberty lens

Examine S.30 through a civil-liberties and limited-government lens. Consider individual rights, privacy, voluntary choice, accountability, and government power. Explain tradeoffs, possible safeguards, and the strongest counterarguments without assuming the proposal is beneficial or harmful.

View full prompt & sources